Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [ 125 I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme
The FDA emphasizes that many compounded semaglutide products may use salt forms (such as semaglutide sodium or acetate), which differ from the active ingredients in approved formulations and lack evidence of safety or efficacy
Oral semaglutide approved by the FDA in 2019 is coformulated with sodium N-[8-(2-hydroxybenzoyl) aminocaprylate] (SNAC)
Chapman IM, Pescovitz OH, Murphy G, Treep T, Cerchio KA, Krupa D, Gertz B, Polvino WJ, Skiles EH, Pezzoli SS, Thorner MO
Get out or die trying: peptide- and protein-based endosomal escape of RNA therapeutics
9 Another case of exposure to dulaglutide during the first trimester of pregnancy for the treatment of type 2 diabetes did not result in any reported birth defects